Proton Beam Radiation for Brain Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how proton beam radiation therapy affects brain function in children with brain tumors. Researchers aim to determine if this treatment improves thinking skills and memory over time. They will use computer tests to track changes in cognitive abilities before and after the treatment, and then annually. Eligible participants are children aged 4 to 21 with a brain tumor who can use a computer and are set to receive or have already started proton therapy. As a Phase 2 trial, this study focuses on measuring the effectiveness of proton therapy in improving cognitive functions in an initial, smaller group of children.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that proton beam radiation therapy is safe for pediatric brain tumor patients?
Research has shown that proton beam radiation therapy (PBRT) is usually well-tolerated by patients with brain tumors. Studies have found that PBRT can target tumors more accurately, reducing radiation exposure to nearby healthy tissues. This precision often results in fewer side effects compared to traditional radiation therapy.
One study found that 29% of patients experienced neurological issues, but skin problems were rare, affecting only 1% of patients. Another source highlights that this therapy can improve overall survival rates while causing less harm to healthy organs.
In summary, while some patients may experience side effects, the precision of PBRT often results in a lower risk of serious problems compared to older radiation methods.12345Why are researchers excited about this trial?
Researchers are excited about proton beam radiation therapy for children with central nervous system tumors because it offers a more precise way to target tumors while sparing healthy surrounding tissue. Unlike traditional radiation therapies that can affect a larger area, proton beams can be controlled to release their energy directly at the tumor site, potentially reducing side effects and damage to developing brains. This precision is particularly important for children, as their brains are still growing, and minimizing harm can lead to better cognitive outcomes long-term.
What evidence suggests that proton beam radiation therapy is effective for improving neurocognitive outcomes in pediatric brain tumor patients?
Research has shown that proton beam radiation therapy (PBRT) can protect healthy brain tissue when treating tumors. Studies have found that PBRT targets the tumor directly, reducing radiation exposure to surrounding healthy brain areas. This focused approach is linked to fewer long-term side effects and better preservation of cognitive skills, such as memory and concentration. Early results suggest that children receiving PBRT for brain tumors may experience less decline in these skills compared to those receiving traditional radiation. In this trial, participants will undergo NIH Toolbox Cognitive Battery testing to assess cognitive outcomes. By lowering the risk of harming healthy tissue, PBRT may support better overall cognitive abilities in young patients.26789
Who Is on the Research Team?
Stephanie Perkins, M.D.
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants receive proton beam radiation therapy (PBRT) with baseline neurocognitive testing completed prior to the end of the first week
Follow-up
Participants undergo follow-up neurocognitive testing 6-12 months after completion of PBRT and annually thereafter
What Are the Treatments Tested in This Trial?
Interventions
- NIH Toolbox Cognitive Battery
- Proton Beam Radiation Therapy
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
* This study will use the NIH Toolbox Cognitive Battery computer testing software to investigate the cognitive outcomes in children with CNS tumors receiving PBRT. * Participants recruited for the study will complete one 45-minute testing session prior to the completion of the first week of radiation therapy. * They will then complete serial tests 6-12 months after the completion of PBRT and then yearly thereafter.
Proton Beam Radiation Therapy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
- Esophageal adenocarcinoma
- Esophageal squamous cell carcinoma
- Gastroesophageal junction tumors
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
Citations
Proton Beam Therapy for Pediatric Tumors of the Central ...
By sparing a large volume of the brain from radiation doses, proton beam therapy aims at reducing long-term side effects and preserving ...
Tracking Outcomes in Proton Therapy for Cancer
A proton beam delivers a targeted dose of radiation directly to the tumor or desired target—but very little radiation to surrounding tissues.
The effectiveness and safety of proton beam radiation ...
Proton beam radiotherapy (PBT) reduces the volume of irradiated tissue outside the tumour target volume which may potentially reduce toxicity.
Proton beam radiation therapy and the overall survival of adult ...
Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors. Int J Radiat Oncol ...
Preservation of Neurocognition after Proton Beam ...
Proton beam radiation therapy reduces dose to healthy brain tissue and thereby decreases the risk of treatment-related decline in neurocognition.
Proton Beam Therapy & CNS Tumor Survival
Conclusions. The use of PBT in patients diagnosed with CNS tumors was associated with improved OS compared to photon RT. In the stratified ...
Evaluating the safety and efficacy of proton radiotherapy for ...
5-year overall survival reached 81% in treated patients. ... Neurological complications were observed in 29% of patients. ... Low incidence of dermatological (1%) ...
8.
cancer.gov
cancer.gov/news-events/cancer-currents-blog/2020/proton-therapy-safety-versus-traditional-radiationIs Proton Therapy Safer than Traditional Radiation? - NCI
After 3 years, 46% of patients in the proton therapy group and 49% of those in the traditional radiation therapy group were cancer free. Fifty- ...
9.
mayoclinic.org
mayoclinic.org/medical-professionals/pediatrics/news/proton-beam-therapy-for-pediatric-cancers/mac-20576795Proton beam therapy for pediatric cancers
Proton beam therapy allows reduction in radiation dose to healthy tissues and organs while delivering the required dose to the tumor.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.